MFSD13A
Transmembrane protein 180
Also known as: bA18I14.8, C10orf77, FLJ22529, MF13A_HUMAN, TMEM180
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14CX5
- Gene
- MFSD13A
- Ensembl
- ENSG00000138111
- Chromosome
- 10
- Canonical length
- 517 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
517 residues, UniProt reviewed canonical sequence.
>Q14CX5|MFSD13A
1 MGLGQPQAWL LGLPTAVVYG SLALFTTILH NVFLLYYVDT FVSVYKINKM AFWVGETVFL
61 LWNSLNDPLF GWLSDRQFLS SQPRSGAGLS SRAVVLARVQ ALGWHGPLLA LSFLAFWVPW
121 APAGLQFLLC LCLYDGFLTL VDLHHHALLA DLALSAHDRT HLNFYCSLFS AAGSLSVFAS
181 YAFWNKEDFS SFRAFCVTLA VSSGLGFLGA TQLLRRRVEA ARKDPGCSGL VVDSGLCGEE
241 LLVGSEEADS ITLGRYLRQL ARHRNFLWFV SMDLVQVFHC HFNSNFFPLF LEHLLSDHIS
301 LSTGSILLGL SYVAPHLNNL YFLSLCRRWG VYAVVRGLFL LKLGLSLLML LAGPDHLSLL
361 CLFIASNRVF TEGTCKLLTL VVTDLVDEDL VLNHRKQAAS ALLFGMVALV TKPGQTFAPL
421 LGTWLLCFYT GHDLFQQSLI TPVGSAHPWP EPPAPAPAQA PTLRQGCFYL LVLVPITCAL
481 LQLFTWSQFT LHGRRLHMVK AQRQNLSQAQ TLDVKMVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MFSD13A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 17 nTPM
- basal ganglia: 13 nTPM
- cerebral cortex: 11 nTPM
- skin: 11 nTPM
- lung: 8.6 nTPM
- hippocampal formation: 8.5 nTPM
Single-cell type
- syncytiotrophoblasts: 58 nCPM
- epicardial cells: 39 nCPM
- alveolar cells type 2: 34 nCPM
- tuft cells: 23 nCPM
- transitional alveolar cells: 21 nCPM
- neutrophil progenitors: 21 nCPM
Immune cell
- myeloid DC: 4.5 nTPM
- classical monocyte: 4.3 nTPM
- eosinophil: 3.5 nTPM
- memory B-cell: 3.5 nTPM
- naive CD8 T-cell: 3.2 nTPM
- intermediate monocyte: 3.1 nTPM
Brain region
- cerebellum: 29 nTPM
- basal ganglia: 27 nTPM
- cerebral cortex: 24 nTPM
- hippocampal formation: 23 nTPM
- amygdala: 21 nTPM
- thalamus: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.05
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MFS transporter superfamily
- MFS/sugar transport protein
- Transmembrane protein 180
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MFSD13A as an antibody target. Whether an autoantibody or antibody against MFSD13A could matter depends on whether native MFSD13A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MFSD13A is annotated at the cell surface, where native MFSD13A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MFSD13A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...